FindTrial
Sign In

To compare efficacy of two drugs, dexmedetomidine and remifentanil affect adult diabetic patients having heart surgery and requiring heart-lung machine

Effect of dexmedetomidine and remifentanil on perioperative glycaemic control in adult diabetic cardiac surgical patient requiring cardiopulmonary bypass:A Randomised controlled study - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/07/092106
Enrollment
64
Registered
2025-07-31
Start date
Unknown
Completion date
Unknown
Last updated
2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I248- Other forms of acute ischemic heart disease Health Condition 2: O- Medical and Surgical

Interventions

Intervention1: Effect of remifentanil on perioperative glycaemic control in adult diabetic cardiac patients: Group REM will receive remifantil before induction of anesthesia at rate 0.25 mcg/kg/hr d

Sponsors

DR PEMA NAMGYAL SHERPA
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.ASA II-III 2.Patients able to comprehend and willing to participate 3.Patients scheduled for elective cardiac surgery through midline sternotomy with use of CPB

Exclusion criteria

Exclusion criteria: 1. Patients refusal to participate 2. Participate with left ventricular ejection less than 30% 3. Emergent or redo surgeries 4. Minimal invasive cardiac surgeries 5. Patients with heart block or heart rate less than 50 beats/min 6. Use of regional anesthesia 7. Severe organ dysfunction (Renal/ Liver insufficiencies).

Design outcomes

Primary

MeasureTime frame
Effects of dexmedetomidine and remifentanil infusion on blood glucose levelTimepoint: T0 before induction till 5th postoperative period—

Secondary

MeasureTime frame
Study the requirements of regular insulin, effect of glucose control in patients with controlled & uncontrolled diabetes & hemodynamic parametersTimepoint: T0 before induction till 5th postoperative period—

Countries

India

Contacts

Public ContactDR ALOK KUMAR BHARTI

Ind ira GandhiInstitute of Medical Science

fpemanamgyal444@gmail.com7076681639

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026